ACC 2021精彩搶先看!5場LBCT,3場特色臨床研究,都有哪些看點?( 二 )
時間:5月16日 , 10:45 a.m. – 12:15 p.m. ET研究1:The FLOWER-MI Randomized Trial: Fractional Flow Reserve-guided Versus Angio-guided Multivessel Revascularization In ST-Elevation Myocardial Infarction Patients FLOWER-MI隨機對照研究:在ST段抬高型心肌梗死(STEMI)患者中 , 進行血流儲備分數(shù)(FFR)引導和血管造影引導的多支血管血運重建術的比較研究2:A Prospective, Multicenter, Randomized, Open-label Trial To Compare Efficacy And Safety Of Clopidogrel Versus Ticagrelor In Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention 一項前瞻性、多中心、隨機、開放標簽的臨床試驗:在穩(wěn)定的急性心梗患者進行PCI后 , 比較氯吡格雷與替格瑞洛的療效和安全性研究3:Host Exam Randomized Controlled Trial: Aspirin Vs. Clopidogrel During Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention HOST-EXAM隨機對照試驗:在PCI后 , 比較進行阿司匹林和氯吡格雷單藥治療的長期療效研究4:Late Outcomes Of A 1-hour High Sensitivity Troponin T Protocol In Suspected Acute Coronary Syndromes: A Randomized Clinical Trial 在疑似急性冠脈綜合征(ACS)患者中 , 進行1h高敏感肌鈣蛋白T檢測的隨機臨床試驗的最新結果研究5:Randomized Sham-controlled RADIANCE-HTN TRIO Trial: Endovascular Ultrasound Renal Denervation To Treat Hypertension Resistant To A Fixed Dose Triple Medication Pill RADIANCE-HTN TRIO隨機假對照試驗:血管內超聲下去腎神經(jīng)支配術治療對固定劑量三聯(lián)藥物耐藥的高血壓特色臨床研究 II
時間:5月16日 , 2 – 3:30 p.m. ET研究1:SAFE-PAD Study: Initial Report From the Safety Assessment Of Femoropopliteal Endovascular Treatment With Paclitaxel-coated Devices Study SAFE-PAD研究:使用紫杉醇涂層裝置進行股腘動脈血管內治療的安全性評估的初步報告研究2:One-year Follow-up of the Reality Randomized Clinical Trial: Effect Of A Restrictive Vs Liberal Blood Transfusion Strategy On Major Cardiovascular Events Among Patients With Acute Myocardial Infarction And Anemia REALITY試驗1年隨訪結果:在急性心梗合并貧血的患者中 , 對比限制性輸血與自由輸血策略對患者主要心血管事件的影響研究3:World Alliance Societies Of Echocardiography COVID Study: Human Vs Machine Learning-based Echocardiography Analysis As Predictor Of Outcomes In Acute Covid-19 Patients 世界超聲心動圖聯(lián)盟學會(WASE)COVID試驗:在急性COVID-19患者中 , 將基于人和計算機的超聲心動圖分析作為患者預后預測指標的對比研究4:Coalition ACTION Trial: Randomized Clinical Trial To Evaluate A Routine Full Anticoagulation Strategy In Patients With Coronavirus Infection (SARS-CoV-2) Admitted To Hospital COALITION ACTION試驗:在新冠病毒感染住院患者中 , 評估常規(guī)進行全面抗凝策略的隨機臨床試驗研究5:Inspiration-S Double Blind Randomized Controlled Trial: Atorvastatin Versus Placebo In Critically-ill Patients With Covid-1 INSPIRATION-S雙盲隨機對照試驗:在危重COVID-19患者中 , 對比阿托伐他汀與安慰劑的療效研究6:ACC 2020 Well Being Study: Impact of COVID-19 on the Global Cardiovascular Workforce ACC 2020 WELL BEING研究:COVID-19對全球心血管醫(yī)生職業(yè)狀態(tài)的影響LBCT Ⅳ
時間:5月17日 , 8:00 a.m. – 9:30 a.m. ET研究1:Benefits Of Sodium Glucose Co-transporter-1/2 Inhibition With Sotagliflozin Across The Full Spectrum Of Ejection Fraction, Including Heart Failure With Preserved Ejection Fraction 在不同射血分數(shù)的心衰(包括射血分數(shù)保留的心衰)患者中 , 進行鈉-葡萄糖共轉運蛋白1/2(SGLT2)抑制劑索格列凈治療的獲益研究2:Primary Results of the Connect-hf Randomized Clinical Trial: Care Optimization Through Patient And Hospital Engagement Clinical Trial For Heart Failure CONNECT-HF隨機試驗的主要結果:由患者和醫(yī)院參與的心衰護理優(yōu)化臨床試驗研究3:Results of the LIFE Trial: Sacubitril/Valsartan (LCZ696) In Patients With Advanced Heart Failure And Reduced Ejection Fraction LIFE試驗結果:沙庫巴曲纈沙坦(LCZ696)在晚期射血分數(shù)降低的心衰(HFrEF)患者中的作用研究4:Pirfenidone In Heart Failure With Preserved Ejection Fraction 吡非尼酮治療射血分數(shù)保留的心衰(HFpEF)研究5:Secondary Analysis From GALACTIC-HF: Impact Of Ejection Fraction On The Therapeutic Effect Of Omecamtiv Mecarbil In Patients With Heart Failure And Reduced Ejection Fraction GALACTIC-HF試驗的二次分析:在HFrEF患者中 , 探究射血分數(shù)對omecamtiv mecarbil治療效果的影響LBCT Ⅴ
時間:5月17日 , 10:45 a.m. – 12:15 p.m. ET研究1:Therapeutic Hypothermia Following Out-Of-Hospital Cardiac Arrest: A Randomized Trial Comparing Mild And Moderate Therapeutic Hypothermia 院外心臟驟停的低溫治療:比較輕度和中度低溫治療的隨機對照試驗研究2:Prague OHCA Study: Hyperinvasive Approach In Refractory Out-of-Hospital Cardiac Arrest: An Open-label Randomized Controlled Trial PRAGUE OHCA開放標簽、隨機試驗:難治性院外心臟驟停患者的侵入性治療研究3:RAFT-AF: A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial In Patients With Heart Failure And High Burden Atrial Fibrillation RAFT-AF隨機試驗:在心衰和房顫高負荷患者中 , 對比基于消融的房顫心律控制和心率控制的療效研究4:Acute Alcohol Consumption And Discrete Atrial Fibrillation Events 急性飲酒和隨機房顫事件研究5:Finerenone And New Onset Of Atrial Fibrillation Or Flutter In Patients With Chronic Kidney Disease And Type 2 Diabetes 在慢性腎病和2型糖尿病患者中 , Finerenone應用與新發(fā)房顫或房撲的關系特色臨床研究 Ⅲ
推薦閱讀
- 上班族的周末 精彩放松樂不停
- 2021尿痛尿頻尿急尿血怎么辦 如何治療見效快又安全
- 變化的乳房讓性生活精彩不斷
- 減肥最快秘籍 科學減肥讓你精彩瘦不停
- 烤瓷牙價格表詳細介紹,一口好牙笑出精彩人生!
- 啥屬相的人,財局三合,祿馬行大運,2021年有吉星涌現(xiàn),諸事順利
- 2021下半年,桃花極旺,能遇到傾慕之人,享受甜蜜愛情的3屬相
- 歐洲杯|2-0到2-2,再到3-2!歐洲杯最精彩對決誕生,荷蘭獲7年“首勝”
- 2021年運勢一片大好,前途光明,桃花運不斷的三大星座
- 十二生肖中,3生肖2021年富貴惹不起,橫財出現(xiàn),順利發(fā)財!
